GenMark Diagnostics to Present at Upcoming Investor Conferences
November 07, 2018 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the...
GenMark Diagnostics Reports Third Quarter 2018 Results
October 29, 2018 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics Schedules Third Quarter Financial Results Conference Call for October 29, 2018
October 15, 2018 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Monday,...
GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram-Negative and ePlex Blood Culture Identification Fungal Pathogen Panels
October 02, 2018 16:14 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the...
GenMark Diagnostics Reports Second Quarter 2018 Results
July 30, 2018 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 30, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics to Present at the Canaccord Genuity 38th Annual Growth Conference
July 25, 2018 16:03 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...
GenMark Diagnostics Schedules Second Quarter Financial Results Conference Call for July 30, 2018
July 16, 2018 17:31 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its second quarter earnings results after market close on Monday,...
GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram Positive Panel
June 28, 2018 16:57 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
June 06, 2018 08:00 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...
GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
May 02, 2018 16:03 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK) a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that...